| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jennifer B Hall | |
| Marina A Dobrovolskaia | |||
| Scott E McNeil | |||
| Parag Aggarwal | |||
| Christopher B McLeland | |||
| P2860 | cites work | Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration | Q67023093 |
| Plasma lipoproteins: apolipoprotein structure and function | Q24300750 | ||
| 140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry | Q24306446 | ||
| Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces | Q28281941 | ||
| Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles | Q28651740 | ||
| Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells | Q29615461 | ||
| Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. | Q30342394 | ||
| Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. | Q30344256 | ||
| Structure and function of enzymes adsorbed onto single-walled carbon nanotubes. | Q30349820 | ||
| Dendrimer-protein interactions studied by tryptophan room temperature phosphorescence. | Q30357546 | ||
| Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres | Q31016875 | ||
| Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis | Q33274548 | ||
| Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system | Q33287118 | ||
| Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. | Q33879575 | ||
| Nanoparticulate systems for brain delivery of drugs | Q33938252 | ||
| Drug transport to brain with targeted nanoparticles | Q33985140 | ||
| Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. | Q34040103 | ||
| The use of microdialysis for the determination of plasma protein binding of drugs | Q67480127 | ||
| Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum | Q69121751 | ||
| The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908 | Q69732153 | ||
| Plasma protein adsorption patterns on liposomes: establishment of analytical procedure | Q71345857 | ||
| Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) | Q72294469 | ||
| Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis | Q72315172 | ||
| Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum | Q72552049 | ||
| Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding | Q73311345 | ||
| Interactions of nanoparticles with body proteins--improvement of 2D-PAGE-analysis by internal standard | Q73503856 | ||
| Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption | Q73503867 | ||
| Determination of plasma protein adsorption on magnetic iron oxides: sample preparation | Q73558349 | ||
| Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity | Q73850374 | ||
| Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles | Q73990827 | ||
| Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles | Q77992685 | ||
| Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor | Q79148486 | ||
| Determination of drug plasma protein binding by solid phase microextraction | Q79776764 | ||
| Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics | Q80473061 | ||
| Analytical centrifugation: equilibrium approach | Q81132222 | ||
| Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry | Q82899420 | ||
| Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance | Q93944526 | ||
| Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
| Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes | Q34335325 | ||
| Capture of stealth nanoparticles by the body's defences. | Q34492177 | ||
| Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function | Q34589214 | ||
| Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging | Q34603395 | ||
| Role of the alveolar macrophage in lung injury: studies with ultrafine particles | Q34842701 | ||
| Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 | ||
| Nucleation of protein fibrillation by nanoparticles | Q35785510 | ||
| Nanoparticles as catalysts for protein fibrillation | Q35828940 | ||
| Probing the interactions of proteins and nanoparticles | Q35844538 | ||
| Serum opsonins and liposomes: their interaction and opsonophagocytosis | Q35900905 | ||
| Nanotechnology for the biologist | Q36143597 | ||
| Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 | ||
| Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. | Q36485131 | ||
| The protein-nanomaterial interface | Q36610118 | ||
| The role of complement in inflammation and phagocytosis | Q36845189 | ||
| Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles | Q36933014 | ||
| Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel | Q36944245 | ||
| Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
| Identification of small molecule targets on functional protein microarrays | Q37065160 | ||
| Protein nanoparticles as drug carriers in clinical medicine | Q37142688 | ||
| Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats | Q38548001 | ||
| Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition | Q38549321 | ||
| In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. | Q38549880 | ||
| Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement | Q38555404 | ||
| Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
| An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes | Q38574226 | ||
| Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles | Q40019458 | ||
| Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. | Q40091435 | ||
| Biological approaches to the controlled delivery of drugs: a critical review. | Q40199551 | ||
| Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel | Q40314117 | ||
| Influence of polysaccharide coating on the interactions of nanoparticles with biological systems | Q40382041 | ||
| Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. | Q40499643 | ||
| Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis | Q40638140 | ||
| Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting | Q40947914 | ||
| Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorption | Q41141564 | ||
| Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein | Q41941390 | ||
| The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
| Binding between particles and proteins in extracts: implications for microrheology and toxicity. | Q42802049 | ||
| Development of a high throughput equilibrium dialysis method | Q43565687 | ||
| The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. | Q43737331 | ||
| Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines | Q43738911 | ||
| Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein | Q43796615 | ||
| Experimental and calculated parameters on particle phagocytosis by alveolar macrophages | Q43996750 | ||
| Probing protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements | Q44870295 | ||
| The effect of serum protein fractions on liposome-cell interactions in cultured cells and the perfused rat liver | Q45138857 | ||
| Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin | Q45265632 | ||
| Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush | Q46380814 | ||
| Studies of drug binding to plasma proteins using a variant of equilibrium dialysis | Q46518249 | ||
| Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). | Q46582356 | ||
| Directed assembly of carbon nanotubes at liquid-liquid interfaces: nanoscale conveyors for interfacial biocatalysis | Q46908952 | ||
| Particle size-dependent organ distribution of gold nanoparticles after intravenous administration | Q47249334 | ||
| Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery | Q47325811 | ||
| In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size | Q47369583 | ||
| Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake | Q47405435 | ||
| Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles | Q48003121 | ||
| Plasma Protein Adsorption of Tween 80- and Poloxamer 188-stabilized Solid Lipid Nanoparticles | Q48162744 | ||
| Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain | Q48299076 | ||
| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. | Q48520343 | ||
| Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. | Q48536446 | ||
| Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. | Q48608387 | ||
| Complement activation and protein adsorption by carbon nanotubes. | Q50752357 | ||
| Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). | Q51137239 | ||
| Increasing protein stability through control of the nanoscale environment. | Q51182487 | ||
| Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. | Q51393527 | ||
| Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. | Q51575383 | ||
| Molecular mechanisms of the adsorption of a model protein (human serum albumin) on poly(methylidene malonate 2.1.2) nanoparticles. | Q51605190 | ||
| Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. | Q52548541 | ||
| Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. | Q52937153 | ||
| Functional groups on polystyrene model nanoparticles: Influence on protein adsorption | Q52951619 | ||
| Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. | Q52975133 | ||
| Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. | Q52996852 | ||
| Influence of block copolymers on the adsorption of plasma proteins to microspheres. | Q54247888 | ||
| Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles | Q55167507 | ||
| The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century | Q55167511 | ||
| The Pulmonary Toxicology of Ultrafine Particles | Q58317014 | ||
| Effect of dendrimers on pure acetylcholinesterase activity and structure | Q59923842 | ||
| The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity | Q59924017 | ||
| Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation | Q60482252 | ||
| ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption | Q60775760 | ||
| Anomalous thermal denaturing of proteins adsorbed to nanoparticles | Q62656975 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 428-437 | |
| P577 | publication date | 2009-04-17 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy | |
| P478 | volume | 61 |
| Q38912231 | 15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model |
| Q89702865 | A Melanin-Based Natural Antioxidant Defense Nanosystem for Theranostic Application in Acute Kidney Injury |
| Q92661964 | A Multidisciplinary Approach Toward High Throughput Label-Free Cytotoxicity Monitoring of Superparamagnetic Iron Oxide Nanoparticles |
| Q64250338 | A Smart Nanovector for Cancer Targeted Drug Delivery Based on Graphene Quantum Dots |
| Q33995502 | A general mechanism for intracellular toxicity of metal-containing nanoparticles. |
| Q35232504 | A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. |
| Q36294987 | A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®. |
| Q39111600 | A review on nanoparticle-based technologies for biodetoxification. |
| Q51309453 | A spectroscopic investigation on the interaction of a magnetic ferrofluid with a model plasma protein: effect on the conformation and activity of the protein. |
| Q34187508 | A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media. |
| Q37739965 | A tetraethylene glycol coat gives gold nanoparticles long in vivo half-lives with minimal increase in size |
| Q35174085 | Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition |
| Q42974606 | Accounting for biological aggregation in heating and imaging of magnetic nanoparticles |
| Q42643098 | Acute exposure to zinc oxide nanoparticles does not affect the cognitive capacity and neurotransmitters levels in adult rats |
| Q28397767 | Acute toxicity of nickel nanoparticles in rats after intravenous injection |
| Q57345001 | Advanced design of t and pH dual-responsive PDEAEMA-PVCL core-shell nanogels for siRNA delivery |
| Q35037265 | Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation |
| Q37902143 | Alternative in vitro assays in nanomaterial toxicology |
| Q61805272 | Amorphous aggregation of tau in the presence of titanium dioxide nanoparticles: biophysical, computational, and cellular studies |
| Q90427267 | Amphiphilic nanogels: influence of surface hydrophobicity on protein corona, biocompatibility and cellular uptake |
| Q36870738 | An Evaluation of Blood Compatibility of Silver Nanoparticles |
| Q37809539 | An appraisal of the published literature on the safety and toxicity of food-related nanomaterials |
| Q38848926 | An efficient injectable formulation with block copolymer micelles for hydrophobic antitumor candidate-pyridazinone derivatives |
| Q33658455 | An index for characterization of nanomaterials in biological systems. |
| Q90278729 | Analysing the nanoparticle-protein corona for potential molecular target identification |
| Q33587673 | Analytical strategies for detecting nanoparticle-protein interactions |
| Q92732850 | Antitumor Features of Vegetal Protein-Based Nanotherapeutics |
| Q38222165 | Application of mass spectrometry to characterize localization and efficacy of nanoceria in vivo |
| Q23911868 | Applied nanotoxicology |
| Q90399895 | Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine |
| Q51739696 | Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems. |
| Q45123331 | BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake |
| Q38234567 | Barriers to drug delivery in solid tumors |
| Q36452638 | Beauty is skin deep: a surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules. |
| Q97526260 | Bimetallic Nanoparticles for Antimicrobial Applications |
| Q55354000 | Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats. |
| Q38849743 | Biocompatibility and nanostructured materials: applications in nanomedicine |
| Q37173058 | Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization |
| Q45218737 | Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with "stealth" potential |
| Q38824053 | Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size |
| Q28817501 | Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial |
| Q39013235 | Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction |
| Q38558905 | Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine |
| Q53275631 | Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. |
| Q30369753 | Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. |
| Q29615557 | Biomolecular coronas provide the biological identity of nanosized materials |
| Q35005673 | Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids |
| Q39025870 | Biosafety evaluations of well-dispersed mesoporous silica nanoparticles: towards in vivo-relevant conditions. |
| Q92809833 | Biosafety of unmodified ultrafine gold particles (AuPs) upon interacting with human blood components before systemic use |
| Q36814280 | Biotargeted nanomedicines for cancer: six tenets before you begin |
| Q64940363 | CaCO3 as an Environmentally Friendly Renewable Material for Drug Delivery Systems: Uptake of HSA-CaCO3 Nanocrystals Conjugates in Cancer Cell Lines. |
| Q38567851 | Carbohydrate nanocarriers in biomedical applications: functionalization and construction |
| Q51535351 | Carbohydrate structure dependent hemocompatibility of biomimetic functional polymer brushes on surfaces. |
| Q57947042 | Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona |
| Q38757812 | Carbon Nanotubes Disrupt Iron Homeostasis and Induce Anemia of Inflammation through Inflammatory Pathway as a Secondary Effect Distant to Their Portal-of-Entry |
| Q36414890 | Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization |
| Q41986667 | Cellular Uptake Mechanism of Paclitaxel Nanocrystals Determined by Confocal Imaging and Kinetic Measurement |
| Q28538811 | Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles |
| Q42275706 | Characterisation of the protein corona using tunable resistive pulse sensing: determining the change and distribution of a particle's surface charge |
| Q50860766 | Characterization of protein and peptide binding to nanogels formed by differently charged chitosan derivatives. |
| Q37070584 | Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats |
| Q27021154 | Chemical basis of interactions between engineered nanoparticles and biological systems |
| Q41152019 | Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles |
| Q36394426 | Colloidal stability of polymeric nanoparticles in biological fluids |
| Q51402678 | Comparative study of kanamycin sulphate microparticles and nanoparticles for intramuscular administration: preparation in vitro release and preliminary in vivo evaluation. |
| Q57947087 | Competitive Cellular Uptake of Nanoparticles Made From Polystyrene, Poly(methyl methacrylate), and Polylactide |
| Q57947047 | Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition |
| Q51690443 | Component-Specific Analysis of Plasma Protein Corona Formation on Gold Nanoparticles Using Multiplexed Surface Plasmon Resonance. |
| Q96431684 | Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life |
| Q38865701 | Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona |
| Q48367598 | Covalently Connected Polymer-Protein Nanostructures Fabricated by a Reactive Self-Assembly Approach. |
| Q38232143 | Current strategies for DNA therapy based on lipid nanocarriers |
| Q28383550 | Cytokines as biomarkers of nanoparticle immunotoxicity |
| Q30958719 | Data Mining as a Guide for the Construction of Cross-Linked Nanoparticles with Low Immunotoxicity via Control of Polymer Chemistry and Supramolecular Assembly |
| Q57610427 | Dendrimer-Based Gene Delivery Systems: Administration Routes andIn VivoEvaluation |
| Q47781605 | Dendrimers meet zwitterions: development of a unique antifouling nanoplatform for enhanced blood pool, lymph node and tumor CT imaging. |
| Q49370039 | Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties. |
| Q34216430 | Detection and characterization of subvisible aggregates of monoclonal IgG in serum |
| Q92190033 | Development and application of hyaluronic acid in tumor targeting drug delivery |
| Q90001865 | Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo |
| Q40214900 | Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration |
| Q52583647 | Distributions: The Importance of the Chemist's Molecular View for Biological Materials. |
| Q35642480 | Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism |
| Q26798467 | Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems |
| Q37283351 | Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. |
| Q37856301 | Drug delivery to the CNS and polymeric nanoparticulate carriers |
| Q40716825 | Dual radiolabeling as a technique to track nanocarriers: the case of gold nanoparticles. |
| Q30362004 | Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment. |
| Q39143913 | Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity |
| Q38720925 | Effect of Gold Nanoparticle Size and Coating on Labeling Monocytes for CT Tracking. |
| Q48298889 | Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics. |
| Q35175551 | Effect of a Pluronic(®) P123 formulation on the nitric oxide-generating drug JS-K. |
| Q49641882 | Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow. |
| Q34473963 | Effect of nano-scale curvature on the intrinsic blood coagulation system |
| Q28485162 | Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles |
| Q47295619 | Effect of size and dose on the biodistribution of graphene oxide in mice. |
| Q35538826 | Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. |
| Q39466953 | Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles. |
| Q41856124 | Effects of 15d-PGJ₂-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. |
| Q39527615 | Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles |
| Q34444404 | Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles |
| Q47260839 | Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery |
| Q46166674 | Effects of polymer-coated metal oxide nanoparticles on goldfish (Carassius auratus L.) neutrophil viability and function |
| Q37143010 | Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy |
| Q57367552 | Effects of thermosensitive poly(N-isopropylacrylamide) on blood coagulation |
| Q38837036 | Emerging nanotechnologies for cancer immunotherapy |
| Q26996159 | Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems |
| Q38824421 | Endocytosis in gene therapy with non-viral vectors |
| Q91603635 | Endothelial barrier dysfunction induced by nanoparticle exposure through actin remodeling via caveolae/raft-regulated calcium signalling |
| Q36854172 | Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging |
| Q28383470 | Engineered metal based nanoparticles and innate immunity |
| Q26861914 | Engineered nanomaterial uptake and tissue distribution: from cell to organism |
| Q55668817 | Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design. |
| Q38938407 | EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer. |
| Q42944298 | Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs |
| Q35825413 | Evaluation of silica nanoparticle binding to major human blood proteins. |
| Q92663275 | Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene |
| Q38501675 | Exploiting the novel properties of protein coronas: emerging applications in nanomedicine |
| Q34003696 | Exploration of possible binding sites of nanoparticles on protein by cross-linking chemistry coupled with mass spectrometry. |
| Q47169890 | Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation. |
| Q28392772 | Exposure to TiO2 nanoparticles increases Staphylococcus aureus infection of HeLa cells |
| Q42660933 | Fabrication of corona-free nanoparticles with tunable hydrophobicity |
| Q58073502 | Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensions |
| Q104073447 | Foreign body responses in mouse central nervous system mimic natural wound responses and alter biomaterial functions |
| Q91579285 | Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona |
| Q47864891 | Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs |
| Q39203522 | Functionalized Gold Nanoparticles and Their Biomedical Applications. |
| Q64260983 | Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy |
| Q37137190 | Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy |
| Q89477286 | Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer |
| Q57176835 | Gold Nanoparticles: A Powerful Tool to Visualize Proteins on Ordered Mesoporous Silica and for the Realization of Theranostic Nanobioconjugates |
| Q52394135 | Graphene oxide regulates cox2 in human embryonic kidney 293T cells via epigenetic mechanisms: dynamic chromosomal interactions. |
| Q38899947 | Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers |
| Q92454367 | Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification |
| Q37445335 | Heterogeneity in nanoparticles influences biodistribution and targeting |
| Q41620935 | Hyaluronic Acid Coated Chitosan Nanoparticles Reduced the Immunogenicity of the Formed Protein Corona. |
| Q35612858 | ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance |
| Q35839945 | Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles |
| Q51810666 | IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow. |
| Q30472780 | Immune complement activation is attenuated by surface nanotopography |
| Q50153603 | Immunological Effects of Iron Oxide Nanoparticles and Iron-based Complex Drug Formulations: Therapeutic Benefits, Toxicity, Mechanistic Insights, and Translational Considerations. |
| Q39080233 | Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation |
| Q90923083 | Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System |
| Q39500030 | Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells |
| Q47334555 | In Vitro Evaluation of Anti-Aggregation and Degradation Behavior of PEGylated Polymeric Nanogels under In Vivo Like Conditions. |
| Q47147898 | In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles. |
| Q99579065 | In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy |
| Q39040950 | In vitro gastrointestinal digestion increases the translocation of polystyrene nanoparticles in an in vitro intestinal co-culture model. |
| Q37906630 | In vivo biodistribution of nanoparticles |
| Q36289257 | In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles |
| Q36373902 | In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis |
| Q61804285 | Indoor nanoscale particulate matter-induced coagulation abnormality based on a human 3D microvascular model on a microfluidic chip |
| Q91950939 | Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future |
| Q35487583 | Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin |
| Q38068247 | Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact |
| Q37812005 | Inorganic nanoparticles in cancer therapy |
| Q38074442 | Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy |
| Q59146736 | Interaction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon Resonance |
| Q36922850 | Interaction of silicon-based quantum dots with gibel carp liver: oxidative and structural modifications |
| Q37835287 | Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems |
| Q38056690 | Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions |
| Q91868695 | Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles |
| Q41601504 | Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation |
| Q97595568 | Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo |
| Q97073785 | Lipid nanoparticle technology for therapeutic gene regulation in the liver |
| Q26765446 | Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators |
| Q38229624 | Liver cell-targeted delivery of therapeutic molecules |
| Q34948337 | Low toxicity and long circulation time of polyampholyte-coated magnetic nanoparticles for blood pool contrast agents |
| Q36617753 | Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application |
| Q64235044 | MWCNT interactions with protein: surface-induced changes in protein adsorption and the impact of protein corona on cellular uptake and cytotoxicity |
| Q36283461 | Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine |
| Q28390303 | Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects |
| Q87606554 | Manipulating hemoglobin oxygenation using silica nanoparticles: a novel prospect for artificial oxygen carriers |
| Q64075041 | Mathematical modeling in cancer nanomedicine: a review |
| Q42555568 | Measuring the grafting density of nanoparticles in solution by analytical ultracentrifugation and total organic carbon analysis |
| Q28385549 | Mechanistic Study on the Reduction of SWCNT-induced Cytotoxicity by Albumin Coating |
| Q38494930 | Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences |
| Q50897815 | Methods of protein corona isolation for magnetic nanoparticles. |
| Q52603493 | MiRNA extraction from cell-free biofluid using protein corona formed around carboxyl magnetic nanoparticles. |
| Q35613017 | Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts |
| Q31124745 | Microwave-assisted green synthesis of superparamagnetic nanoparticles using fruit peel extracts: surface engineering, T 2 relaxometry, and photodynamic treatment potential |
| Q40562574 | Modulation of Protein Fouling and Interfacial Properties at Carbon Surfaces via Immobilization of Glycans Using Aryldiazonium Chemistry. |
| Q35814950 | Modulation of Silica Nanoparticle Uptake into Human Osteoblast Cells by Variation of the Ratio of Amino and Sulfonate Surface Groups: Effects of Serum. |
| Q89510832 | Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins |
| Q61798103 | Molecular interaction of fibrinogen with zeolite nanoparticles |
| Q50926807 | Monodispersity of magnetic immuno-nanoprobes enhances the detection sensitivity of low abundance biomarkers in one drop of serum. |
| Q51736820 | Morphology-Variable Aggregates Prepared from Cholesterol-Containing Amphiphilic Glycopolymers: Their Protein Recognition/Adsorption and Drug Delivery Applications. |
| Q59794223 | Multifunctional Platform Based on Electroactive Polymers and Silica Nanoparticles for Tissue Engineering Applications |
| Q58812768 | Multifunctional Silica Nanoparticles for Covalent Immobilization of Highly Sensitive Proteins |
| Q40765081 | Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy. |
| Q45789061 | Multiwavelength transmission spectroscopy revisited for the characterization of the protein and polystyrene nanoparticle interactions |
| Q39561959 | Nano meets biology: structure and function at the nanoparticle interface |
| Q37967661 | Nanobiotechnology for the capture and manipulation of circulating tumor cells |
| Q27027067 | Nanocarriers for vascular delivery of antioxidants |
| Q59204660 | Nanocarriers with dual pH-sensitivity for enhanced tumor cell uptake and rapid intracellular drug release |
| Q35381211 | Nanodetoxification: emerging role of nanomaterials in drug intoxication treatment |
| Q64089402 | Nanomaterial Exposure Induced Neutrophil Extracellular Traps: A New Target in Inflammation and Innate Immunity |
| Q37857064 | Nanomaterials: applications in cancer imaging and therapy. |
| Q38383478 | Nanomedicine for gene therapy. |
| Q28395287 | Nanoparticle Uptake: The Phagocyte Problem |
| Q58585993 | Nanoparticle probes for quantifying supramolecular determinants of biosurface affinity |
| Q45719861 | Nanoparticle stability in biologically relevant media: influence of polymer architecture. |
| Q38123458 | Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. |
| Q38167942 | Nanoparticle vaccines |
| Q50226473 | Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics. |
| Q28384480 | Nanoparticles and direct immunosuppression |
| Q37612053 | Nanoparticles and the blood coagulation system. Part II: safety concerns |
| Q33634320 | Nanoparticles and the immune system |
| Q57377197 | Nanoparticles combined with growth factors: recent progress and applications |
| Q34010233 | Nanoparticles for imaging, sensing, and therapeutic intervention |
| Q26825418 | Nanoparticulate adjuvants and delivery systems for allergen immunotherapy |
| Q38218145 | Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia |
| Q47818560 | Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses. |
| Q35943647 | Nanotechnology and the treatment of HIV infection. |
| Q39631113 | Nanotoxicity: how the body develops a way to reduce the toxicity of carbon nanotubes |
| Q57345630 | Nanotoxicology: Contemporary Issues and Future Directions |
| Q37624470 | Negatively charged metal oxide nanoparticles interact with the 20S proteasome and differentially modulate its biologic functional effects |
| Q64819927 | Neurotheranostics as personalized medicines |
| Q47447868 | Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation |
| Q38183853 | New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy. |
| Q38364473 | No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine |
| Q52431943 | Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities. |
| Q58097605 | Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency |
| Q26991771 | Novel formulations for antimicrobial peptides |
| Q49575081 | Occupational exposure to ultrafine particles in police officers: no evidence for adverse respiratory effects. |
| Q91693455 | Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification |
| Q64264041 | Overview of Carbon Nanotubes for Biomedical Applications |
| Q90579730 | Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies |
| Q37693763 | Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation. |
| Q36299217 | PEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting. |
| Q34149180 | PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics |
| Q55449441 | PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. |
| Q38401187 | Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures |
| Q47794249 | Particle Targeting in Complex Biological Media |
| Q38807176 | Past, Present, and Future Drug Delivery Systems for Antiretrovirals |
| Q60184483 | Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications |
| Q38881377 | Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide |
| Q38947400 | Phosphatidylcholine-coated iron oxide nanomicelles for in vivo prolonged circulation time with an antibiofouling protein corona |
| Q91912625 | Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging |
| Q58547073 | Physicochemical Characterization of FRET-Labelled Chitosan Nanocapsules and Model Degradation Studies |
| Q35190894 | Physicochemical characterization of nanoparticles and their behavior in the biological environment |
| Q28392831 | Physicochemical properties of nanomaterials: implication in associated toxic manifestations |
| Q39005101 | Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles |
| Q47570893 | Plasma protein adsorption and biological identity of systemically administered nanoparticles |
| Q27026623 | Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics |
| Q39027154 | Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization |
| Q51186932 | Polyelectrolyte Oil-Core Nanocarriers for Localized and Sustained Delivery of Daunorubicin to Colon Carcinoma MC38 Cells: The Case of Polysaccharide Multilayer Film in Relation to PEG-ylated Shell. |
| Q38902155 | Potential of biofluid components to modify silver nanoparticle toxicity |
| Q57947038 | Pre-coating with protein fractions inhibits nano-carrier aggregation in human blood plasma |
| Q44549040 | Probing lipid coating dynamics of quantum dot core micelles via Förster resonance energy transfer |
| Q41949821 | Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. |
| Q51084208 | Probing the binding affinity of plasma proteins adsorbed on Au nanoparticles. |
| Q26740580 | Progress and perspectives on targeting nanoparticles for brain drug delivery. |
| Q30714285 | Progress on the diagnosis and evaluation of brain tumors. |
| Q92989097 | Protein Adsorption: A Feasible Method for Nanoparticle Functionalization? |
| Q38674654 | Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment. |
| Q57947040 | Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers |
| Q37651354 | Protein bio-corona: critical issue in immune nanotoxicology |
| Q26853351 | Protein corona - from molecular adsorption to physiological complexity |
| Q91866982 | Protein corona formed on silver nanoparticles in blood plasma is highly selective and resistant to physicochemical changes of the solution |
| Q46454818 | Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity |
| Q46029993 | Protein corona on magnetite nanoparticles and internalization of nanoparticle-protein complexes into healthy and cancer cells. |
| Q39274203 | Protein corona: a new approach for nanomedicine design |
| Q97644950 | Protein electrostatics: From computational and structural analysis to discovery of functional fingerprints and biotechnological design |
| Q36142197 | Protein-based photothermal theranostics for imaging-guided cancer therapy |
| Q37850776 | QSAR modeling of nanomaterials |
| Q28392542 | Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models |
| Q35214069 | Quantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MS |
| Q51429705 | RNA-binding proteins are a major target of silica nanoparticles in cell extracts. |
| Q39093144 | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology |
| Q35300570 | Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes |
| Q91669702 | Recent Advances in the Use of Focused Ultrasound for Magnetic Resonance Image-Guided Therapeutic Nanoparticle Delivery to the Central Nervous System |
| Q92798768 | Recent expansions of novel strategies towards the drug targeting into the brain |
| Q36889993 | Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology |
| Q50282486 | Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. |
| Q59134586 | Regulatory Aspects of Oncologicals: Nanosystems Main Challenges |
| Q33713687 | Relationships between Poly(ethylene glycol) Modifications on RNA-Spherical Nucleic Acid Conjugates and Cellular Uptake and Circulation Time |
| Q57161039 | Renal Clearable Luminescent Gold Nanoparticles: From Bench to Clinics |
| Q36058748 | Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles |
| Q56976666 | Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles |
| Q89913837 | Reversible Control of Protein Corona Formation on Gold Nanoparticles Using Host-Guest Interactions |
| Q38821105 | Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential. |
| Q39447640 | Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population |
| Q53230602 | Self-Assembled Fluorescent Nanoparticles from π-Conjugated Small Molecules: En Route to Biological Applications. |
| Q47861975 | Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces. |
| Q45787949 | Serum enhanced cytokine responses of macrophages to silica and iron oxide particles and nanomaterials: a comparison of serum to lung lining fluid and albumin dispersions |
| Q36468223 | Serum protein adsorption and excretion pathways of metal nanoparticles |
| Q55450179 | Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. |
| Q35527009 | Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization |
| Q35393931 | Silica nanoconstruct cellular toleration threshold in vitro |
| Q35703091 | Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. |
| Q38807256 | Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. |
| Q35039920 | Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions |
| Q47324311 | Spontaneous protein desorption from self-assembled monolayer (SAM)-coated gold nanoparticles. |
| Q46048775 | Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications. |
| Q27027780 | Stimulating antitumor immunity with nanoparticles |
| Q30836736 | Strategies for interfacing inorganic nanocrystals with biological systems based on polymer-coating |
| Q38017713 | Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers |
| Q38567353 | Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors |
| Q35055270 | Structural determinants for protein adsorption/non-adsorption to silica surface |
| Q57795199 | Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles |
| Q97523873 | Sulfoxide-Containing Polymer-Coated Nanoparticles Demonstrate Minimal Protein Fouling and Improved Blood Circulation |
| Q58493156 | Surface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitro |
| Q39298856 | Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. |
| Q37334228 | Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles |
| Q42268182 | Surface hydrolysis-mediated PEGylation of poly(N-isopropyl acrylamide) based nanogels |
| Q33850450 | Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer Cells |
| Q42284052 | Synthesis and Characterization of PMBN as A Biocompatible Nanopolymer for Bio-Applications |
| Q39393477 | Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications |
| Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
| Q38703125 | Taxane-Grafted Metal-Oxide Nanoparticles as a New Theranostic Tool against Cancer: The Promising Example of Docetaxel-Functionalized Titanate Nanotubes on Prostate Tumors. |
| Q90223130 | Temperature-Responsive Hydrophobic Silica Nanoparticle Ultrasound Contrast Agents Directed by Phospholipid Phase Behavior |
| Q53127398 | Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses. |
| Q51004786 | The Impact of Protein Corona Formation on the Macrophage Cellular Uptake and Biodistribution of Spherical Nucleic Acids. |
| Q50220267 | The Nature of a Hard Protein Corona Forming on Quantum Dots Exposed to Human Blood Serum. |
| Q41843707 | The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a Ligand |
| Q47391647 | The Protein Corona around Nanoparticles Facilitates Stem Cell Labeling for Clinical MR Imaging. |
| Q58803479 | The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery |
| Q91973095 | The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System |
| Q58493134 | The Role of the Protein Corona in Fiber Structure-Activity Relationships |
| Q34447943 | The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry |
| Q38996952 | The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility |
| Q27013605 | The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells |
| Q28384138 | The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity |
| Q28386401 | The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles |
| Q38168566 | The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats |
| Q38722460 | The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response |
| Q42913725 | The effect of zinc oxide nanoparticles on the structure of the periplasmic domain of the Vibrio cholerae ToxR protein. |
| Q35223423 | The fate of calcium carbonate nanoparticles administered by oral route: absorption and their interaction with biological matrices |
| Q28085280 | The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery |
| Q38176391 | The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior |
| Q43078999 | The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. |
| Q28083583 | The janus facet of nanomaterials |
| Q54645900 | The nanotoxicology revolution. |
| Q40106774 | The role of nanotechnology in the treatment of viral infections. |
| Q38236719 | The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy. |
| Q36807868 | The role of surface functionality in determining nanoparticle cytotoxicity |
| Q50046147 | The surface chemistry determines the spatio-temporal interaction dynamics of quantum dots in atherosclerotic lesions. |
| Q38886457 | The surfactant dipalmitoylphophatidylcholine modifies acute responses in alveolar carcinoma cells in response to low-dose silver nanoparticle exposure |
| Q38555085 | Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy |
| Q39665792 | Thermally Triggered Cellular Uptake of Quantum Dots Immobilized with Poly(N-isopropylacrylamide) and Cell Penetrating Peptide |
| Q96809436 | Thermodynamic parameters at bio-nano interface and nanomaterial toxicity: A case study on BSA interaction with ZnO, SiO2 and TiO2 |
| Q38655546 | Titanium dioxide nanoparticles preferentially bind in subdomains IB, IIA of HSA and minor groove of DNA. |
| Q28071613 | Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms |
| Q28383168 | Toxicity of nanomaterials |
| Q38255894 | Toxicity of single-walled carbon nanotubes |
| Q38009230 | Toxico-/biokinetics of nanomaterials |
| Q38968620 | Translocation of differently sized and charged polystyrene nanoparticles in in vitro intestinal cell models of increasing complexity. |
| Q53461387 | Tumor-acidity activated surface charge-conversion of polymeric nanocarriers for enhanced cell adhesion and targeted drug release. |
| Q33816969 | Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. |
| Q57348100 | Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T1/T2 MRI contrast agents |
| Q38954326 | Two-Dimensional Nanomaterials for Biomedical Applications: Emerging Trends and Future Prospects |
| Q36010379 | Ultrapure laser-synthesized Si-based nanomaterials for biomedical applications: in vivo assessment of safety and biodistribution. |
| Q93273323 | Unbiased Identification of the Liposome Protein Corona using Photoaffinity-based Chemoproteomics |
| Q91801319 | Understanding the Influence of a Bifunctional Polyethylene Glycol Derivative in Protein Corona Formation around Iron Oxide Nanoparticles |
| Q36739647 | Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future |
| Q55336529 | Use of Submicron Vaterite Particles Serves as an Effective Delivery Vehicle to the Respiratory Portion of the Lung. |
| Q36844202 | Using the Power of Organic Synthesis for Engineering the Interactions of Nanoparticles with Biological Systems |
| Q38834911 | Utilizing the protein corona around silica nanoparticles for dual drug loading and release |
| Q41868722 | Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas |
| Q51732274 | Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior. |
| Q38652067 | Versatility of Pyridoxal Phosphate as a Coating of Iron Oxide Nanoparticles |
| Q37403163 | X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface |
| Q48400402 | X-ray microscopy and tomography detect the accumulation of bare and PEG-coated gold nanoparticles in normal and tumor mouse tissues. |
| Q34074782 | Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption |
| Q36382827 | Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol. |
| Q54358989 | [Use of nanoparticles in ophthalomology]. |
| Q58732419 | biological fate of poly(vinylalcohol) microbubbles in mice |
| Q37449500 | pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma |
| Q53091050 | pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin. |
Search more.